Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)–associated Nephritis Versus Myeloperoxidase ANCA–associated Nephritis

Aladdin J. Mohammad and Mårten Segelmark
The Journal of Rheumatology July 2014, 41 (7) 1366-1373; DOI: https://doi.org/10.3899/jrheum.131038
Aladdin J. Mohammad
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Department of Rheumatology, Skåne University Hospital, Lund; Department of Nephrology UHL, Östergötland County Council; and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Aladdin.mohammad@med.lu.se
Mårten Segelmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 41 no. 7 1366-1373
DOI 
https://doi.org/10.3899/jrheum.131038
PubMed 
24882836

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication March 4, 2014
  • Published online July 1, 2014.

Article Versions

  • Latest version (June 1, 2014 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014

Author Information

  1. Aladdin J. Mohammad⇑ and
  2. Mårten Segelmark
  1. From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Department of Rheumatology, Skåne University Hospital, Lund; Department of Nephrology UHL, Östergötland County Council; and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  2. A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; Department of Rheumatology, Skåne University Hospital; M. Segelmark, MD, PhD, Department of Nephrology UHL, Östergötland County Council; Department of Medical and Health Sciences, Linköping University.
  1. Address correspondence to Dr. A.J. Mohammad, Department of Rheumatology, Skåne University Hospital, 221 85, Lund, Sweden. E-mail: Aladdin.mohammad{at}med.lu.se

Article usage

Article usage: May 2014 to January 2023

AbstractFullPdf
May 2014506
Jun 2014233541
Jul 20145912051
Aug 2014881321
Sep 2014109717
Oct 20145215
Nov 20144412
Dec 20143159
Jan 20155325
Feb 20152034
Mar 20151666
Apr 20151713
May 20151752
Jun 20151911
Jul 20152543
Aug 20152807
Sep 20152321
Oct 20152324
Nov 201526810
Dec 20151734
Jan 20162412
Feb 20161233
Mar 20161853
Apr 20161112
May 2016434
Jun 20162745
Jul 20162412
Aug 20161622
Sep 20163224
Oct 20162334
Nov 20162702
Dec 20164211
Jan 20174172
Feb 20174772
Mar 20173554
Apr 20175186
May 20174130
Jun 20171864
Jul 20174322
Aug 20172033
Sep 20172321
Oct 20172722
Nov 20173520
Dec 20173164
Jan 20182911
Feb 20182474
Mar 20182132
Apr 20182600
May 20184434
Jun 20182010
Jul 20182521
Aug 20181721
Sep 20182423
Oct 20182341
Nov 20183332
Dec 201822102
Jan 20192822
Feb 20192842
Mar 20191121
Apr 20192543
May 20191672
Jun 20191163
Jul 20192644
Aug 20193711
Sep 20193871
Oct 20192521
Nov 20192840
Dec 20192933
Jan 202013110
Feb 20203214
Mar 20202422
Apr 20200175
May 20204133
Jun 2020475
Jul 2020289
Aug 2020153
Sep 202031910
Oct 202011713
Nov 202010166
Dec 202071614
Jan 20217189
Feb 2021133014
Mar 20217248
Apr 20215225
May 20216227
Jun 202102111
Jul 20213249
Aug 20211256
Sep 20211388
Oct 20211352
Nov 20217367
Dec 20214254
Jan 202222115
Feb 20229299
Mar 20222174
Apr 20222196
May 2022112311
Jun 202222512
Jul 20221167
Aug 20223285
Sep 20226325
Oct 20224195
Nov 202262011
Dec 2022585
Jan 202351168

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 7
1 Jul 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)–associated Nephritis Versus Myeloperoxidase ANCA–associated Nephritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)–associated Nephritis Versus Myeloperoxidase ANCA–associated Nephritis
Aladdin J. Mohammad, Mårten Segelmark
The Journal of Rheumatology Jul 2014, 41 (7) 1366-1373; DOI: 10.3899/jrheum.131038

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)–associated Nephritis Versus Myeloperoxidase ANCA–associated Nephritis
Aladdin J. Mohammad, Mårten Segelmark
The Journal of Rheumatology Jul 2014, 41 (7) 1366-1373; DOI: 10.3899/jrheum.131038
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY
GLOMERULONEPHRITIS
VASCULITIS
SURVIVAL
ENDSTAGE RENAL DISEASE

Related Articles

Cited By...

More in this TOC Section

  • Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis
  • Immunosuppressive Therapies in Ear, Nose, and Throat Involvement in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results From a Multicenter Retrospective Cohort Study
  • Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis
Show more Article

Similar Articles

Keywords

  • ANTINEUTROPHIL CYTOPLASMIC ANTIBODY
  • glomerulonephritis
  • vasculitis
  • survival
  • endstage renal disease

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire